Sunflower Bank’s Gilead Sciences GILD Stock Holding History

Sunflower Bank’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-4,227	Closed	-$273K	–	212
2021 Q1	$273K	Sell	4,227 -836	-17%	-$53.9K	0.04%	164
2020 Q4	$295K	Buy	+5,063	New	+$306K	0.05%	152

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Sunflower Bank's GILD Position: Q2 2021 in Review

Sunflower Bank sold out of Gilead Sciences (GILD) in Q2 2021, closing a stake of 4,227 shares — an estimated $273K sold.

Sunflower Bank first reported a position in GILD in Q4 2020 and held it in 2 quarters. The position peaked at $295K in Q4 2020. 1,544 funds tracked by Wall St. Rank hold GILD as of Q2 2021.

Sunflower Bank reported no remaining Gilead Sciences position as of Q2 2021 after selling out during the quarter.
Sunflower Bank sold 4,227 Gilead Sciences shares in Q2 2021, an estimated $273K.
Sunflower Bank first reported a position in Gilead Sciences in Q4 2020 and held it in 2 quarters.
Sunflower Bank's Gilead Sciences position peaked at $295K in Q4 2020.
1,544 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2021.

Based on Sunflower Bank's 13F filing for Q2 2021, filed 10 Sep 2021.